Speakers dinner

Pharma Boehringer Ingelheim Progressive Pulmonary Fibrosis: Myths and Facts 17.30 - Welcome and introductions, Marlies Wijsenbeek (The Netherlands) 17.35 - It is important for patients with ILD to receive an accurate differential diagnosis? Myth or fact?, Maria Molina Molina (Spain) 17.50 - There are multiple drugs approved to treat PF ILD - Myth or fact?, [...]

ILDs: Early diagnosis 16.30 - Interstitial lung abnormalities, Sara Tomassetti (Italy) 17.00 - Early diagnosis for ILDs, Wim Wuyts (Belgium) Chairs: Radu Crișan Dabija (Romania), Claudia Ravaglia (Italy)

Coffee Break

Roundtable Patient organizations session, Liam Galvin (Ireland), Steve Jones (Ireland) Chairs: Irina Strâmbu (Romania), Robert Arsene (Romania)

Poster discussion Peritoneal Sarcoidosis or Peritoneal Tuberculosis? A Challenging Case, Shambhu Aryal (USA) A Case of Refractory Pulmonary Mycetoma in a Patient with Sarcoidosis Treated with CT guided Percutaneous Cryoablation, Shambhu Aryal (USA) Outcomes of ECMO in acute exacerbation of interstitial pneumonia are comparable to those of non-interstitial pneumonia, Shinichiro Ohshimo (Japan) IPF, Ioana Dinu [...]

Lunch Break

IPF and PF-ILD 10.40 - New treatments in PF, Luca Richieldi (Italy) 11.05 - Acute exacerbations in pulmonary fibrosis, Azuma Arata (Japan) 11.30 - IPF diagnosis: guideline recommendations, Ganesh Raghu (USA) 12.00 - Primary and secondary UIP: a unified diagnostic entity?, Athol Wells (UK) 12.30 - Advances in non-IPF pulmonary fibrosis, Marlies Wijsenbeek (The Netherlands) [...]

Coffee Break

Pulmonary fibrosis – the basics 8.30 - Novel insights into pathogenesis, Katerina Antoniou (Greece) 9.00 - Genetics in ILDs – time to act, Jan Grutters (Nieuwegein, The Netherlands) 9.25 - Biomarkers of progression, Francesco Bonella (Germany) 9.50 - Cardiac consequences of pulmonary fibrosis, Roxana Maria Nemeș (Romania) Chairs: Ionela Belaconi (Romania), Ganesh Raghu (USA)